RT Journal Article
T1 Acute kidney injury: Renal disease in the ICU.
A1 Seller Pérez, Gemma Luisa
A1 Mas Font, Sonia
A1 Pérez Calvo, C.
A1 Villa Díaz, Patricia
A1 Celaya López, Mikel
A1 Herrera-Gutiérrez, Manuel Enrique
K1 Insuficiencia renal aguda
K1 Cuidados intensivos
K1 Biomarcadores
AB Acute kidney injury (AKI) in the ICU frequently requires costly supportive therapies, has high morbidity, and its long-term prognosis is not as good as it has been presumed so far. Consequently, AKI generates a significant burden for the healthcare system. The problem is that AKI lacks an effective treatment and the best approach relies on early secondary prevention. Therefore, to facilitate early diagnosis, a broader definition of AKI should be established, and a marker with more sensitivity and early-detection capacity than serum creatinine - the most common marker of AKI - should be identified. Fortunately, new classification systems (RIFLE, AKIN or KDIGO) have been developed to solve these problems, and the discovery of new biomarkers for kidney injury will hopefully change the way we approach renal patients. As a first step, the concept of renal failure has changed from being a "static" disease to being a "dynamic process" that requires continuous evaluation of kidney function adapted to the reality of the ICU patient.
PB Elsevier
YR 2016
FD 2016-08
LK https://hdl.handle.net/10630/41322
UL https://hdl.handle.net/10630/41322
LA eng
NO Seller-Pérez G, Más-Font S, Pérez-Calvo C, Villa-Díaz P, Celaya-López M, Herrera-Gutiérrez ME. Acute kidney injury: Renal disease in the ICU. Med Intensiva. 2016 Aug-Sep;40(6):374-82. English, Spanish. doi: 10.1016/j.medin.2016.05.002. Epub 2016 Jul 4. PMID: 27388683.
DS RIUMA. Repositorio Institucional de la Universidad de Málaga
RD 21 ene 2026